NCT00257712View on ClinicalTrials.gov

SMART: Somatotrophics, Memory, and Aging Research Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
AgingMild Cognitive Impairment
Interventions
DRUG

TH9507 human growth hormone releasing hormone (GHRH)

1mg subcutaneous injection given daily for 20 weeks

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Washington

OTHER

NCT00257712 - SMART: Somatotrophics, Memory, and Aging Research Trial | Biotech Hunter | Biotech Hunter